Validation using sEVs-specific markers (CD63, CD81, and TSG101) demonstrated a noteworthy upregulation in MCI and AD, indicating PsEVs numbers are increased in disease conditions (Fig. 2A–D). The gene discussed is TSG101; the disease is Alzheimer disease.